Trachoma, the world's leading infectious cause of blindness, is one of the priority diseases targeted by VISION 2020. There has been significant advancement towards elimination since the launch of VISION 2020. In June 2019, WHO announced a 91% global reduction in the number of people at risk of trachoma, from 1.5 billion in 2002 to 142.2 million today. During the same period, the number of people requiring surgery for trachomatous trichiasis (TT), the late blinding stage of trachoma, reduced from 7.6 million to 2.5 million -a 68% reduction. Nine countries across all endemic WHO regions have also been validated for achieving elimination.
Progress towards VISION 2020's mission and objectives include: 
Robust evidence to support disease elimination efforts
International commitments and increased investment led to the largest ever infectious disease survey -the Global Trachoma Mapping Project (GTMP). From 2012-2016, GTMP screened over 2.6 million people for trachoma across 29 countries and identified areas where interventions needed to be scaled up. Since 2016, Tropical Data has supported health ministries through the full survey process -from planning and protocol development to application of the survey outputs. Data collected by GTMP and Tropical Data have mobilised resources to scale up all components of the WHO-endorsed SAFE strategy (surgery, antibiotics, facial cleanliness, environmental improvements) and have contributed to over 566 million doses of antibiotics being distributed and nearly 1.5 million TT operations being conducted since 2011.
Improved human resources, infrastructure and technology for eye health
In recent years, programmes have included strategies to effectively use limited human resources in resource-poor settings. 1 In Kenya, Tanzania and Chad, national programmes are upskilling ophthalmic nurses and ophthalmic clinical officers to carry out and manage TT operations. In Ethiopia, which accounts for 44% of the global burden of trachoma, the national programme is training general health workers to provide eye care services, including TT surgery, in order to improve coverage rates. Furthermore, new innovations, such as the TT tracker, is helping national programmes to track surgical performance for individual surgeons, so supervisors know when enhanced supervision or additional training is needed. 
Conclusion
With VISION 2020 coming to an end next year, the eye health sector can celebrate advancements towards building sustainable eye health systems. The WHO World Report on Vision, published in October 2019, provides a strategic path to progress towards objectives set by VISION 2020. However, to achieve targets, trachoma interventions must be included in national eye health care plans and health systems must be equipped to deliver comprehensive eye health care for entire populations, including people with disabilities and other hard to reach populations.
Beyond VISION 2020: universal eye health coverage and the elimination of trachoma
